This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Paychex (PAYX) Set to Report Q3 Earnings: What to Expect?
by Zacks Equity Research
Paychex's (PAYX) third-quarter fiscal 2022 earnings and revenues are likely to have increased year over year.
UiPath (PATH) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
UiPath's (PATH) fourth-quarter 2022 earnings and revenues are expected to have improved sequentially.
Reasons to Retain Xerox (XRX) Stock in Your Portfolio For Now
by Zacks Equity Research
Xerox's (XRX) ongoing investments in Xerox Business Solutions, indirect market channels and European sales channels are helping it expand its small and mid-sized markets.
Initial Claims Drop to 52-Year Low: Top 5 Staffing Picks
by Nalak Das
We have narrowed our search to five staffing stocks. These are: CCRN, KFRC, KFY, RHI, DLHC.
Cross Country Healthcare (CCRN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed at $21.45 in the latest trading session, marking a -1.42% move from the prior day.
Charles River (CRAI) Up on Diversified Business Amid Talent Cost
by Zacks Equity Research
Charles River (CRAI) has a diversified business with service offerings across areas of functional expertise, client base and geographical regions.
DocuSign (DOCU) Gains From eSignature Strength Amid Expense Woes
by Zacks Equity Research
DocuSign (DOCU) remains focused on continuously acquiring eSignature customers, expanding eSignature use cases within existing customers and improving its offerings.
Interpublic (IPG) Stock Up 26.2% in a Year: What's Behind It?
by Zacks Equity Research
Consecutive better-than-expected top and bottom-line performances and shareholder-friendly moves have been benefiting Interpublic's (IPG) stock.
6 Reasons to Invest in Automatic Data Processing (ADP) Now
by Zacks Equity Research
Acquisition strategy and initiatives to streamline and expand its business should drive Automatic Data Processing's (ADP) prospects.
Tap 5 Broker-Friendly Bets to Navigate Choppy Markets
by Maharathi Basu
Investors should add broker-friendly stocks like Cross Country Healthcare (CCRN), Builders FirstSource (BLDR), Build-A-Bear Workshop (BBW), Casey's General Stores (CASY) and CNO Financial Group (CNO) to their respective portfolios for handsome returns.
Nielsen (NLSN) Rejects Buyout Offer Citing Undervaluation
by Zacks Equity Research
Nielsen (NLSN) stock falls following the company's rejection of its buyout by a consortium of private equity groups. Nevertheless, NLSN stands strong on robust fundamentals.
Booz Allen (BAH) to Gain From EverWatch Buyout: Here's How
by Zacks Equity Research
The deal is expected to boost Booz Allen's (BAH) cyber, software development and analytics potential for reinforcing national security services.
Earnings Estimates Moving Higher for Cross Country (CCRN): Time to Buy?
by Zacks Equity Research
Cross Country (CCRN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Cross Country Healthcare (CCRN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed at $22.51 in the latest trading session, marking a +1.44% move from the prior day.
TransUnion's (TRU) New Partnership Set to Improve Digital Leasing
by Zacks Equity Research
TransUnion's (TRU) partnership with Funnel Leasing combines its rental screening solutions likeResidentScore and ResidentID products with the Funnel platform.
Reasons to Retain Booz Allen Hamilton (BAH) in Your Portfolio
by Zacks Equity Research
Booz Allen Hamilton's (BAH) solutions business creates differentiated business models and sales channels.
TransUnion (TRU) Teams Up With UMortgage, FinLocker for USafe App
by Zacks Equity Research
The partnership enables consumers to use the USafe app powered by FinLocker to track their credit health through TransUnion (TRU).
Reasons to Hold Broadridge (BR) Stock in Your Portfolio
by Zacks Equity Research
Broadridge (BR) has a consistent track record of rewarding shareholders through dividends.
Reasons to Add Maximus (MMS) Stock to Your Portfolio Now
by Zacks Equity Research
With more than 40 years of experience, Maximus has grown to be a leading operator of government health and human services programs globally.
What's in the Cards for Accenture (ACN) in Q2 Earnings?
by Zacks Equity Research
Accenture's (ACN) second-quarter fiscal 2022 earnings and revenues are expected to have improved year over year.
What's in the Cards for Hut 8 Mining (HUT) in Q4 Earnings?
by Zacks Equity Research
Hut 8 Mining's (HUT) fourth-quarter 2021 earnings and revenues are expected to have improved year over year.
Cross Country Healthcare (CCRN) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed at $19.22 in the latest trading session, marking a +0.68% move from the prior day.
6 Reasons to Add Robert Half (RHI) Stock to Your Portfolio Now
by Zacks Equity Research
Robert Half's (RHI) wholly-owned subsidiary, Protiviti, is strongly positioned in the market, and is also a solid revenue performer.
Reasons to Retain FactSet (FDS) Stock in Your Portfolio
by Zacks Equity Research
The recent acquisition of Cobalt Software is expected to enhance FactSet's (FDS) data and workflow solutions, and expand its private markets offering.
5 Reasons to Add ABM Industries (ABM) Stock to Your Portfolio
by Zacks Equity Research
The acquisition of Able Services is expected to strengthen ABM Industries' engineering and technical services, and expand its sustainability and energy efficiency offerings.